We are live on ! Find out more
KB

Kimelman & Baird Portfolio holdings

AUM $1.22B
1-Year Est. Return 11.47%
This Fund
S&P 500
This Quarter Est. Return
-2.9%
1 Year Est. Return
+11.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.22B
AUM Growth
-$86.4M
Cap. Flow
-$26.2M
Cap. Flow %
-2.15%
Top 10 Hldgs %
42.8%
Holding
275
New
12
Increased
27
Reduced
50
Closed
12

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.07M
2
CSCO icon
Cisco
CSCO
+$6.05M
3
NVDA icon
NVIDIA
NVDA
+$3M
4
TRV icon
Travelers Companies
TRV
+$2.49M
5
AXP icon
American Express
AXP
+$1.07M

Top Sells

Rank Stock Value
1
NSC icon
Norfolk Southern
NSC
+$16.9M
2
JPM icon
JPMorgan Chase
JPM
+$7.16M
3
MA icon
Mastercard
MA
+$4.01M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.2M
5
SOLS
Solstice Advanced Materials
SOLS
+$1.85M

Sector Composition

Rank Sector Weight
1 Industrials 20.74%
2 Financials 18.47%
3 Technology 18.41%
4 Consumer Discretionary 15.76%
5 Healthcare 8.45%

No holdings matched the selected filter criteria.

7 8 9 10 11

Similar funds

DPI
Diversified Portfolios Inc Bloomfield Hills, Michigan $1.22B AUM 11.83% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
AG
Atairos Group Bryn Mawr, Pennsylvania $1.22B AUM 38.2% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
GC
Gillson Capital Chicago, Illinois $1.22B AUM 7.54% 1-Year Est. Return
LWIC
Leith Wheeler Investment Counsel Vancouver, British Columbia, Canada $1.21B AUM 12.04% 1-Year Est. Return

Kimelman & Baird's Q1 2026 Portfolio in Review

As of Q1 2026, Kimelman & Baird held 275 positions worth $1.22B, down 6.6% from $1.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Kimelman & Baird's Q1 2026 filing shows 12 new, 27 increased, 50 reduced and 12 closed positions. Its largest new stake was Travelers Companies: 8,514 shares worth $2.48M. The largest sale was Norfolk Southern, an estimated $16.9M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

  • Kimelman & Baird's largest Q1 2026 buy was Travelers Companies: 8,514 shares worth $2.48M.
  • Kimelman & Baird added most to Regeneron Pharmaceuticals in Q1 2026, an estimated $8.07M increase.
  • Kimelman & Baird's biggest Q1 2026 reduction was Norfolk Southern, cutting an estimated $16.9M.
  • Kimelman & Baird fully exited Exact Sciences in Q1 2026, selling an estimated $203K.
  • Kimelman & Baird's ten largest holdings make up 43% of its $1.22B portfolio in Q1 2026.
  • Kimelman & Baird opened 12 new positions and closed 12 in Q1 2026.
  • Kimelman & Baird's portfolio value fell 6.6% quarter-over-quarter to $1.22B.

Based on Kimelman & Baird's 13F filing for Q1 2026, filed 13 May 2026.